Divergent clinical course of epidermodysplasia verruciformis in siblings

International Journal of Dermatology

Volumn 36, Issue 6, 1997, Pages 442-445

  Cortés Franco, Roberto ^a   Tyring, Stephen K ^b   Vega, Elisa ^b   Payne, Deborah ^b   Granados, Julio ^b   Dominguez Soto, Luciano ^b  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ETRETINATE; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; HUMAN TISSUE; MALE; SQUAMOUS CELL CARCINOMA; WART VIRUS;

EID: 1842370824     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1997.tb01126.x     Document Type: Article

References (5)

1. Kawashima M. Epidermodysplasia verruciformis. J Dermatol 1992; 19: 707-709.
2. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of immunosurveillance. Am J Med Sci 1992; 304: 174-179.
3. Pfister H. Human papillomaviruses and skin cancer. Semin Cancer Biol 1992; 3: 263-271.
4. Jablonska S, Dabrowski J, Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovavirus in oncogenesis. Cancer Res 1972; 32: 585.
5. Jablonska S, Orth G. Epidermodysplasia verruciformis. Clin Dermatol 1985; 3: 83-96.